Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. - Wikidata - awgldk - TriplyDB

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

http://www.wikidata.org/entity/Q36475245

about

Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis Immunosuppressive drugs and fertility Pregnancy, sex and hormonal factors in multiple sclerosis.Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.Multiple sclerosis and pregnancy; What a neurologist may be asked for?A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis.Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events Pregnancy in multiple sclerosis: a questionnaire study.Natalizumab in Multiple Sclerosis: Long-Term Management.Risk evaluation and monitoring in multiple sclerosis therapeutics.A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.Sex and gender issues in multiple sclerosis.Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults Disease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.What do healthcare providers advise women with multiple sclerosis regarding pregnancy?Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.Disease modification in multiple sclerosis: an update.Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.A changing treatment landscape for multiple sclerosis: challenges and opportunities.Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.An overview of pregnancy-related issues in patients with multiple sclerosis.Multiple sclerosis and family planning.Impairment of human neural crest cell migration by prolonged exposure to interferon-beta.Treatment of multiple sclerosis during pregnancy - safety considerations.Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar.Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.Glatiramer acetate during early pregnancy: A prospective cohort study.Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.[Interferon-β1b in multiple sclerosis therapy: more than 20 years clinical experience].Multiple sclerosis and pregnancy prescriptions.

P2860

Q26777686-0175B447-EED6-4D00-A1A5-CF536DC79970 Q26778587-A0D10416-A2D8-43B2-AF8A-F06ADF0723AA Q30354175-47E6791F-06DD-47FF-B89B-240DFC671881 Q30354658-71AD8C31-28E6-4FEB-B0FF-A7326AD8809E Q30428993-3A107AAC-FEA7-4A5D-BB71-2F8CC192B04B Q30716854-408E6F0C-E807-415C-957A-9F27576B2280 Q31162052-F65C4106-4DB9-4DB7-8699-7643A053E291 Q33629433-7C2704E3-E17D-40B4-97B6-FE1B300CE13E Q33717231-9C2F4FDC-68C5-4BAC-96C4-9407C7729F47 Q33754882-8984B8F8-4509-48BE-93AB-2244AB9F7D4F Q34513188-3120BFD9-4245-4A60-B20A-D0C8AF37AFEB Q36153283-5E01667D-21B7-4816-9578-54062C87FC09 Q36389688-95DE0A63-4445-4789-98E6-35FD8E9677CC Q36484448-9F5B7803-2706-4829-ACE9-0D5DCF87EDF4 Q36975701-4DF3014A-5E4D-441C-9DA9-6C22CF0A127A Q36999743-3F675BCD-E13A-4B2D-B92D-D8C717DED976 Q37058811-B17749DA-EC64-4CE3-A7D9-D5A9BF142CF7 Q37200641-EAEFB95A-1370-4B2F-90DA-C45922DF8BFE Q37547683-A1259525-85F6-415D-9942-84F99A88988F Q37661566-3A64F7E6-9FCD-471E-871E-00C58F2A2305 Q37703741-C61B26FC-8082-4786-8EAB-FEAE8B5B5C9E Q38085336-0F3C41D0-8E54-45A6-93CE-3A8D68B025AF Q38125249-F081DF07-D409-4AB7-A927-2FC3BEF81AF5 Q38150405-02802985-9E2E-4519-A502-A43B6066C4E3 Q38150823-C4151A9B-D3D7-4A81-B567-10C07D209E9F Q38151555-F041729D-F190-4BA4-9847-E8C63FD0044A Q38180166-B6841827-4851-4847-8B05-99C10C52197C Q38379249-7F1BE031-E06A-4B01-B4FB-BDD0FBBFC63C Q38449394-B15AD081-7252-412F-BB28-89B4B53E3F89 Q38587675-1E2B13BD-F883-4EC7-B0D8-BC1413522CFB Q38649287-473A6459-8D81-4AEF-9716-4F425427213C Q38862416-358154F8-97C3-46CB-ABB6-5910E9684991 Q38883520-427E107B-7F11-4293-B787-824B02CC3553 Q39021942-8C76EE85-00E6-4544-94ED-522A4B841A8B Q39391443-6692A231-8021-4F34-AB08-18186DCED7E5 Q39964998-D7FE6B1F-9643-46EA-9838-8E92005800A7 Q40120131-C746DCBA-D8EE-4BAE-AEAF-1C7A5BAE3CA3 Q44106109-DF7E3DA3-701A-465E-AE28-60719C785645 Q45155454-2806E34D-9BFA-4032-8A02-8E3E730F4386 Q45796699-9F19E2FD-0B16-4C11-9C20-9D31BE624FA7

P2860

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

http://www.wikidata.org/entity/Q36475245

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

@ast

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

@en

type

label

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

@ast

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

@en

prefLabel

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

@ast

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

@en

P1433

Q36475245-684E0DF4-08D7-42A6-B9E9-6860DA025195

P1476

Q36475245-8F66751A-7DFD-4E38-A8FE-0EF2DE4D1C4A

P2093

Q36475245-43F148C6-54F4-4B92-B865-EB45517836E7

Q36475245-710B9638-7003-46C4-B9A0-262220B3AB18

Q36475245-A10B36CE-08A2-4AC2-AA1C-CC19B524F9FF

Q36475245-C204EBB4-F1C2-4E14-975D-4BD6DE91DCE0

Q36475245-DD8E8B95-F348-406E-AE39-EB75D25C97F0

P2860

Q36475245-01FF2183-E66D-437E-94D1-A8DFE67E5816

Q36475245-07A8B9A4-3654-4AEA-BA27-1D759C79BCD7

Q36475245-1492E39C-75BC-4F09-BE52-CDC87986C607

Q36475245-1DDFA88A-189C-4CAC-B182-30D816BE6E2D

Q36475245-4E7251AF-058A-4A00-B6E5-2A227EF1535C

Q36475245-58BE0B75-E9AE-407F-8AAC-8EE240522FF0

Q36475245-64CC8475-1F90-4A49-8151-C0DB0A5AC80A

Q36475245-74E3EE8B-A62B-4BBA-82A6-D29877E70613

Q36475245-76799F91-35FD-4E80-B437-41C047E5AF52

Q36475245-85266471-B4AC-4981-A38D-77175AD17325

P304

Q36475245-49341409-7BC6-450F-A7F8-EBB5E2F06A06

P31

Q36475245-81A90561-5558-4CD9-9D20-086499156473

P356

Q36475245-1D6954E6-D5D4-42AF-951A-660956B225AB

P407

Q36475245-5D0FF4BF-BF26-495E-B6EA-6916B57F696F

P433

Q36475245-D68186C9-ECF1-4073-B814-E5790C029186

P478

Q36475245-3936CA7A-EBB7-4FBC-B874-2555966758EC

P50

Q36475245-06D2ECAC-D27B-4365-8519-CAE033667AF9

P577

Q36475245-D9C03B35-1DF9-43BF-9ED1-8F90BBD95019

P5875

Q36475245-6DB7CEF9-6D34-4D6D-B0F6-855BE78C7E4B

P698

Q36475245-57B6174E-E70F-4EE4-B9CC-4D4DFDB72437

P921

Q36475245-0DA1EF85-BB13-4D45-8B81-502C5FF334C4

P932

Q36475245-A9F78113-185D-44D6-93C7-1F75B3B5D5F7

P356

WNL.0B013E3182698C64

P1433

P1476

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

@en

P2093

Anne Synnes

http://www.w3.org/2001/XMLSchema#string

Bing Wei Wang

http://www.w3.org/2001/XMLSchema#string

Colleen Guimond

http://www.w3.org/2001/XMLSchema#string

Dessa Sadovnick

http://www.w3.org/2001/XMLSchema#string

Ellen Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sclerosis

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparison.

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.

Part 2: evidence evaluation and management of potential or perceived conflicts of interest: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.

Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.

Parenthood and immunomodulation in patients with multiple sclerosis.

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.

Pregnancy and multiple sclerosis: the initial results from a Brazilian database.

P304

1130-1135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3182698C64

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230763528

http://www.w3.org/2001/XMLSchema#string

P698

22933738

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3525300

http://www.w3.org/2001/XMLSchema#string